GSK 44.58 0.04 / GlaxoSmithKline PLC ADS Downgrades | Benzinga

Thursday, April 19, 2012

Financial Breakfast: Morning News Summary for April 19, 2012 (BAC, Bonds, CHK, CVI, DD, Earnings, EBAY, FFIV, GILD, GSK, HGSI, LUV, MS, News, PM, Futures, Guidance, Upgrades, Commodities, Downgrades, Forex, Technicals, FDA, M&A, Events, Global, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Thu, 07:38am)

Tuesday, February 07, 2012

Financial Breakfast: Morning News Summary for February 07, 2012 (ACHN, AON, BOCH, Bonds, BP, Earnings, EMR, GLW, GSK, News, TM, URBN, WMGI, Futures, Guidance, Upgrades, Commodities, Downgrades, Forex, Technicals, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas / Tue, 08:19am)

Wednesday, January 19, 2011

Morgan Stanley Downgrades GlaxoSmithKline to Underweight (GSK) (Analyst Color, GSK, Downgrades, Analyst Ratings / Wed, 01:12pm)

Wednesday, September 15, 2010

Benzinga's Top Downgrades (NOK, AIV, MU, GSK) (AIV, GSK, MU, NOK, Downgrades, Markets, Analyst Ratings / Wed, 07:58am)
Jefferies Downgrades GSK To Hold (GSK, Downgrades, Markets, Analyst Ratings / Wed, 06:33am)
Jefferies Downgrades GSK On Avandia's Removal Risk (GSK, Downgrades, FDA, Intraday Update, Markets, Analyst Ratings / Wed, 06:17am)

Thursday, February 18, 2010

XenoPort (XNPT) Shares Fall 65% After FDA Rejection (GSK, News, XNPT, Downgrades, Price Target, FDA, Markets, Analyst Ratings, Movers / Thu, 08:56pm)
FDA Rejects XNPT, GSK Gabapentin Prodrug, Horizant (Analyst Color, GSK, XNPT, Downgrades, Analyst Ratings / Thu, 11:41am)

Friday, October 23, 2009

Benzinga’s Top Downgrades (CB, POT, GSK, SPWRA) (CB, GSK, POT, SPWRA, USA, Downgrades, Intraday Update, Markets, Analyst Ratings, Movers / Fri, 11:33am)